Attached files
| file | filename |
|---|---|
| EX-10.17 - EXHIBIT 10.17 - Hoth Therapeutics, Inc. | s112324_ex10-17.htm |
| EX-10.16 - EXHIBIT 10.16 - Hoth Therapeutics, Inc. | s112324_ex10-16.htm |
| EX-10.15 - EXHIBIT 10.15 - Hoth Therapeutics, Inc. | s112324_ex10-15.htm |
| S-1 - S-1 - Hoth Therapeutics, Inc. | s112324_s1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of our report dated April 27, 2018, relating to the balance sheet of Hoth Therapeutics, Inc. as of December 31, 2017, and the related statements of operations, changes in stockholders’ equity and cash flows for the period from May 16, 2017 (inception) to December 31, 2017, and to the reference to our Firm under the caption “Experts” in the Prospectus.
| /s/ WithumSmith+Brown, PC | |
|
New York, New York |
|
| October 10, 2018 |